![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 39, 40362-40367, September 24, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

From the Department of Immunology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195
Posttranslational modification of histones by acetylation, methylation or phosphorylation has emerged as a major mechanism to modify chromatin structure and gene expression. In most cases, transcriptionally active genes display enhanced binding of acetylated histones in their promoters. Activation of histone acetyltransferases or inhibition of histone deacetylases (HDACs) allows chromatin to assume a more open state permitting transcriptional activators to form a preinitiation complex. To our surprise, treatment of cells with the HDAC inhibitor, trichostatin A (TSA), inhibits selected interferon
(IFN
)-stimulated immediate early genes that are activated by the transcription factors Stat1 and Stat2. However, IFN
activation of IRF-1, which requires tyrosine-phosphorylated Stat1 homodimers binding to a
interferon activation sequence in its promoter is not affected by TSA. Exposure of cells to TSA does not alter tyrosine phosphorylation of Stat1 or Stat2. TSA treatment of cells also does not alter the binding of Stat 1 or Stat2 to the endogenous ISG54 promoter. However, IFN
-stimulated binding of RNA polymerase II to the ISG54 promoter is prevented by TSA. Interestingly, ectopic expression of IRF9 reverses the inhibitory actions of TSA, suggesting that IRF9 functions to recruit RNA polymerase II to the promoter of interferon-stimulated genes. This particular function of IRF9 requires the activity of histone deacetylases.
Received for publication, June 8, 2004
* This work was supported by National Institutes of Health Grant CA77366. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 216-445-9045; Fax: 216-444-8372; E-mail: larnera{at}ccf.org.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. M. Karp, T. T. Tan, R. Mathew, D. Nelson, C. Mukherjee, K. Degenhardt, V. Karantza-Wadsworth, and E. White Role of the Polarity Determinant Crumbs in Suppressing Mammalian Epithelial Tumor Progression Cancer Res., June 1, 2008; 68(11): 4105 - 4115. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. R. Fantin, A. Loboda, C. P. Paweletz, R. C. Hendrickson, J. W. Pierce, J. A. Roth, L. Li, F. Gooden, S. Korenchuk, X. S. Hou, et al. Constitutive Activation of Signal Transducers and Activators of Transcription Predicts Vorinostat Resistance in Cutaneous T-Cell Lymphoma Cancer Res., May 15, 2008; 68(10): 3785 - 3794. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sebastian, M. Serra, A. Yeramian, N. Serrat, J. Lloberas, and A. Celada Deacetylase Activity Is Required for STAT5-Dependent GM-CSF Functional Activity in Macrophages and Differentiation to Dendritic Cells J. Immunol., May 1, 2008; 180(9): 5898 - 5906. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Parker, J. Maxson, A. Mooney, and E. A. Wiley Class I Histone Deacetylase Thd1p Promotes Global Chromatin Condensation in Tetrahymena thermophila Eukaryot. Cell, October 1, 2007; 6(10): 1913 - 1924. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ramsauer, M. Farlik, G. Zupkovitz, C. Seiser, A. Kroger, H. Hauser, and T. Decker Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-{gamma}-inducible gbp2 gene PNAS, February 20, 2007; 104(8): 2849 - 2854. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vlasakova, Z. Novakova, L. Rossmeislova, M. Kahle, P. Hozak, and Z. Hodny Histone deacetylase inhibitors suppress IFN{alpha}-induced up-regulation of promyelocytic leukemia protein Blood, February 15, 2007; 109(4): 1373 - 1380. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zupkovitz, J. Tischler, M. Posch, I. Sadzak, K. Ramsauer, G. Egger, R. Grausenburger, N. Schweifer, S. Chiocca, T. Decker, et al. Negative and Positive Regulation of Gene Expression by Mouse Histone Deacetylase 1 Mol. Cell. Biol., November 1, 2006; 26(21): 7913 - 7928. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Overbergh, K. Stoffels, M. Waer, A. Verstuyf, R. Bouillon, and C. Mathieu Immune Regulation of 25-Hydroxyvitamin D-1{alpha}-Hydroxylase in Human Monocytic THP1 Cells: Mechanisms of Interferon-{gamma}-Mediated Induction J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3566 - 3574. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Nusinzon and C. M. Horvath Positive and Negative Regulation of the Innate Antiviral Response and Beta Interferon Gene Expression by Deacetylation Mol. Cell. Biol., April 15, 2006; 26(8): 3106 - 3113. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamaguchi, A. Lantowski, A. J. Dannenberg, and K. Subbaramaiah Histone Deacetylase Inhibitors Suppress the Induction of c-Jun and Its Target Genes Including COX-2 J. Biol. Chem., September 23, 2005; 280(38): 32569 - 32577. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Nusinzon and C. M. Horvath Histone Deacetylases as Transcriptional Activators? Role Reversal in Inducible Gene Regulation Sci. Signal., August 9, 2005; 2005(296): re11 - re11. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |